Our results add LPAAT-β to the list of PA generating enzymes involved in mTOR signaling and provide further evidence that LPAAT-β is a potential tumor-promoting protein, and validate LPAAT-β as a molecular target for drug discovery in pancreatic cancer. The gene discussed is MTOR; the disease is neoplasm.